BRKRP earnings / call / takeaways

BRKRP Q3 FY26 earnings call: key takeaways

What BRKRP said on its earnings call of November 4, 2026: results against expectations, what changed since last quarter, guidance and the questions analysts pressed on.

By Lician·November 4, 2026·AI-generated from the call transcript and Lician data

Bruker reported Q3 2026 revenue of $874 million, up 1.6% year over year, with non-GAAP EPS of $0.56, up 24% from the prior year (22:58)
The company highlighted strong margin expansion and cost discipline, with improved free cash flow and deleveraging. (22:58)

What changed since last quarter

Guidance for fiscal 2026 was raised, with reported revenue expected to be $3.52 to $3.56 billion, up from previous expectations. (36:48)
The company noted a shift in semi-metrology orders, with some moving to fiscal 2027, and highlighted improved margin visibility for the fourth quarter. (32:50)
The CFO emphasized confidence in double-digit EPS growth for fiscal 2027, with a focus on margin expansion and deep tech growth. (47:23)

Guidance

Metric	This call	Previous call
Revenue	"- Full-year revenue of $3.52 to $3.56 billion " (36:48)	not captured
Revenue	"- Organic revenue growth of 1 to 2 percent " (36:48)	not captured
EPS	"- Non-GAAP EPS growth of 15 to 17 percent " (36:48)	not captured

What analysts pressed on

Whether the $20 million semi-metrology order shift will impact 2027 revenue. (1:12:47)
Concerns about the timing and visibility of U.S. ACA-Gov order growth and its impact on 2027 performance. (1:09:50)
Questions about the sustainability of China's strong order growth and its impact on future revenue. (58:40)

In their words

- "We are on track to achieve our $140 million annualized run rate cost out target." (34:41)
- "It's a high priority for just about every biopharma company." (29:14)

Read the full transcript with the AI summary, or listen on the company's official webcast.

Every past call in full and transcript search come with Lician Pro.

Written by AI from the automatic transcript of the company's public webcast and Lician's earnings data. Each sentence cites the passage it comes from, and a sentence with a figure that is not in its sources was removed. Not investment advice.